MedPath

Cerebral Perfusion Pressure Using Precedex and Other Sedatives

Phase 3
Completed
Conditions
Endotracheal Intubation
ICP Monitoring
Continuous IV Sedation
Interventions
Registration Number
NCT01169467
Lead Sponsor
Duke University
Brief Summary

The purpose of this study is to examine the effects of using dexmedetomidine (Precedex) in addition to the current standard-of-care for sedation.

Detailed Description

Primarily, this study seeks to explore whether there is a difference in mean arterial pressure (MAP) variability, incidence of intracranial hypertension, intracranial pressure (ICP) variability, cerebral perfusion pressure (CPP) and Cerebrovascular pressure reactivity index (PRx) in two groups of subjects.

Patients must be submitted to the ICU and be endotracheally intubated and receiving mechanical ventilation with continuous IV sedation for less than 24 hours after recruitment into the study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
89
Inclusion Criteria
  • Admitted to Duke University Neuro Critical Care Unit (NCCU)
  • Adult (18 years of age or older)
  • Expected Mechanical Ventilation for >48 hours with sedation
  • Intraventricular catheter in situ
Read More
Exclusion Criteria
  • Hypersensitivity to study drugs
  • Prisoners
  • Moribund state or death expected within 24 hours
  • Surgery planned within 24 hours of subject enrollment
  • Receiving study drug, Precedex, prior to entering study
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard-of-Care plus PrecedexStandard-of-Care plus DexmedetomidineSubjects who are treated with dexmedetomidine (Precedex) in addition to the standard of care sedation regiment.
Standard-of-CareStandard-of-CareSubjects who are treated with the standard of care sedation regiment only.
Primary Outcome Measures
NameTimeMethod
Variability of Intracranial Pressure (ICP)Baseline to 24 hours

Variability of intracranial pressure was assessed and listed as the standard deviation of all measurements within 24 hours. Variability was assessed and listed as the standard deviation of all measurements within 24 hours

Change in Pressure Reactivity Index (PRx)Baseline to 24 hours

Using computational methods, the PRx was determined by calculating the correlation coefficient between 20 consecutive, time-averaged data points (60-second periods) of ICP and Arterial Blood Pressure (ABP).

A positive PRx correlation suggests impaired cerebrovascular pressure reactivity, that is, passive transmission of changes in ABP to ICP. A negative PRx correlation indicates good pressure reactivity. Any change in ABP produces inverse changes in ICP.

Secondary Outcome Measures
NameTimeMethod
Cerebral Perfusion Pressure Changes in Patients With Secondary Brain InjuryBaseline to 24 hours

Improved physiologic Response. A higher cerebral perfusion pressure during treatment would be considered an improved physiologic response. A lower cerebral perfusion pressure during treatment would be considered a worse physiologic response.

Amount of Sedative/Analgesic Used During Treatment in Patients With Secondary Brain Injury24 hours

Improved physiologic Response. A lower use of sedatives or analgesic during treatment would be considered an improved physiologic response. An increase in the use of sedatives or analgesic during treatment would be considered a worse physiologic response.

Mean Arterial Blood Pressure (MAP) Variability in Patients With Secondary Brain InjuryBaseline to 24 hours

Improved physiologic Response. A lower variability of mean Arterial Blood pressure during treatment would be considered an improved physiologic response. A higher variability of mean Arterial Blood pressure during treatment would be considered a worse physiologic response. Variability was assessed and listed as the standard deviation of all measurements within 24 hours.

Trial Locations

Locations (1)

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath